Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

SWK Holdings's Return On Capital Employed Insights

According to Benzinga Pro, during Q4, SWK Holdings (NASDAQ:SWKH) earned $6.33 million, a 182.08% increase from the preceding quarter. SWK Holdings also posted a total of $14.96 million in sales, a 56.44% increase since Q3.

Aveanna Healthcare Hldgs's Return On Capital Employed Overview

Aveanna Healthcare Hldgs's Return On Capital Employed Overview

Aveanna Healthcare Hldgs (NASDAQ:AVAH) brought in sales totaling $414.07 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 6137.89%, resulting in a loss of $126.19 million.

Progenity Earnings Perspective: Return On Capital Employed

Progenity Earnings Perspective: Return On Capital Employed

Benzinga Pro data, Progenity (NASDAQ:PROG) reported Q4 sales of $435.00 thousand. Earnings fell to a loss of $92.87 million, resulting in a 112.31% decrease from last quarter.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Looking Into Trxade Group's Return On Capital Employed

According to data from Benzinga Pro, during Q4, Trxade Group's (NASDAQ:MEDS) reported sales totaled $2.40 million. Despite a 39.75% increase in earnings, the company posted a loss of $784.34 thousand.

Looking Into ThermoGenesis Holdings's Return On Capital Employed

ThermoGenesis Holdings (NASDAQ:THMO) brought in sales totaling $2.42 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 61.05%, resulting in a loss of $2.89 million.

AEye's Return On Capital Employed Overview

AEye (NASDAQ:LIDR) brought in sales totaling $416.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 43.93%, resulting in a loss of $25.03 million.

Looking Into Fortress Biotech's Return On Capital Employed

Benzinga Pro data, Fortress Biotech (NASDAQ:FBIO) reported Q4 sales of $18.28 million. Earnings fell to a loss of $68.51 million, resulting in a 49.38% decrease from last quarter.

inkl

Read news from The Economist, FT, and more,
with one subscription

CASI Pharmaceuticals's Return On Capital Employed Insights

CASI Pharmaceuticals's Return On Capital Employed Insights

According to data from Benzinga Pro, during Q4, CASI Pharmaceuticals's (NASDAQ:CASI) reported sales totaled $9.16 million. Despite a 46.15% increase in earnings, the company posted a loss of $5.39 million.

Venus Concept Earnings Perspective: Return On Capital Employed

Venus Concept Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q4, Venus Concept's (NASDAQ:VERO) reported sales totaled $32.63 million. Despite a 53.5% increase in earnings, the company posted a loss of $4.11 million.

Looking Into Tango Therapeutics's Return On Invested Capital

Looking Into Tango Therapeutics's Return On Invested Capital

Benzinga Pro data, Tango Therapeutics (NASDAQ:TNGX) reported Q4 sales of $5.72 million. Earnings fell to a loss of $22.05 million, resulting in a 12.54% decrease from last quarter.

Checkpoint Therapeutics's Return On Capital Employed Insights

Checkpoint Therapeutics's Return On Capital Employed Insights

Checkpoint Therapeutics (NASDAQ:CKPT) brought in sales totaling $16.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 164.15%, resulting in a loss of $29.76 million.

Verastem Oncology's Return On Capital Employed Insights

Verastem Oncology's Return On Capital Employed Insights

According to data from Benzinga Pro, during Q4, Verastem Oncology's (NASDAQ:VSTM) reported sales totaled $545.00 thousand. Despite a 27.67% increase in earnings, the company posted a loss of $16.48 million.

Why NeoGenomics Stock Is Plunging Today

Why NeoGenomics Stock Is Plunging Today

NeoGenomics Inc's (NASDAQ:NEO) CEO Mark Mallon will step down as CEO and member of the Board, effective immediately. The Board has retained Russell Reynolds to search for the Company's next CEO The Board has appointed current Chair Lynn Tetrault, Esq. as Executive Chair and established an Interim Office of the CEO. Read…

Read How EHang Holdings Fared In Q4

Read How EHang Holdings Fared In Q4

EHang Holdings Ltd (NASDAQ:EH) reported fourth-quarter FY21 revenues of RMB8.7 million ($1.4 million), compared with RMB13 million in 3Q21 and RMB54.6 million in 4Q20. The gross margin was 60.1%, compared with 61.8% in Q3. The decrease reflects changes in the revenue mix. Adjusted loss per ADS was $(0.22) or RMB(1.46) compared to…

Get all your
news in one place.

100's of premium titles.
One news app.

Tigress Financial Analyst Sees 45% Upside In Nvidia - Read Why

Tigress Financial analyst Ivan Feinseth raised the price target on NVIDIA Corp (NASDAQ:NVDA) to $410 from $400 and kept a Buy rating. The price target implied an upside of 45.3%. Nvidia's recent analyst day and GPU Technology Conference, or GTC, highlighted new products and their advancement in AI, further powering data centers, gaming,…

Benzinga's Daily Brief On Trending Tickers For March 29, 2022: GameStop, Tesla, OIL ETF And More

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks.

Researchers Accuse Russia's Yandex Of Breach Of User Privacy

Researchers alleged that Russian internet company Yandex NV (NASDAQ:YNDX) had embedded code into apps found on mobile devices that help to transmit user information to Russian servers, the Financial Times reports. Yandex's software helped developers create apps for devices running Apple Inc's (NASDAQ:AAPL) iOS and Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google's Android, systems that ran the vast majority…

Here's How Analysts View Apple's Latest Products, Services

Analysts tried to gauge the impact of Apple Inc's (NASDAQ:AAPL) products and services. Apple is exploring subscription offerings for its hardware products as early as late 2022 or 2023. Morgan Stanley analyst Katy Huberty saw that the average Apple user spent $280 on hardware and added $69 to Apple Services revenue in 2021, implying, Apple…

Get all your
news in one place.

100's of premium titles.
One news app.

10 Biggest Price Target Changes For Tuesday

BTIG cut the price target on NeoGenomics, Inc. (NASDAQ: NEO) from $35 to $28. NeoGenomics shares fell 29.2% to $12.60 in pre-market trading.

Morgan Stanley Downgrades Pinterest Amid Challenges From Facebook, Google

Morgan Stanley analyst Brian Nowak downgraded Pinterest Inc (NYSE:PINS) to Equal Weight from Overweight with a price target of $30, down from $53. The price target implies an upside of 13.4%. Pinterest's user and time spent trends were challenging while it shifted existing time spent toward lower-monetizing creator videos. Nowak acknowledged the edge in larger…

9 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session

Gainers Lovesac (NASDAQ:LOVE) shares moved upwards by 18.7% to $56.0 during Tuesday's pre-market session. The market value of their outstanding shares is at $846.8 million. As per the press release, Q4 earnings came out today.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) stock moved upwards by 45.0% to $0.29 during Tuesday's pre-market session. The company's market cap stands at $8.5 million.

BIO-key Intl: Q4 Earnings Insights

BIO-key Intl (NASDAQ:BKYI) reported its Q4 earnings results on Tuesday, March 29, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

12 Information Technology Stocks Moving In Tuesday's Pre-Market Session

Gainers Ebix (NASDAQ:EBIX) shares increased by 14.9% to $40.0 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.2 billion.

Why Nvidia Stock Is Trading Higher Today

NVIDIA Corp (NASDAQ: NVDA) is trading higher Tuesday morning following bullish analyst coverage from Tigress Financial. Tigress Financial analyst Ivan Feinseth maintained Nvidia with a Buy rating and raised the price target from $400 to $410.

1 … 811 812 813 814

People

Samik Chatterjee

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

395,294 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play